| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |